170 related articles for article (PubMed ID: 31885007)
1. Decreased Level of IL-37 Correlates Negatively with Inflammatory Cytokines in Cerebrospinal Fluid of Patients with Neuro-Behcet's Disease.
Ben Dhifallah I; Borhani-Haghighi A; Hamzaoui A; Hamzaoui K
Iran J Immunol; 2019 Dec; 16(4):299-310. PubMed ID: 31885007
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Behçet disease.
Belghith M; Bahrini K; Kchaou M; Maghrebi O; Belal S; Barbouche MR
Cytokine; 2018 Aug; 108():160-167. PubMed ID: 29625335
[TBL] [Abstract][Full Text] [Related]
3. RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet's disease.
Hamzaoui K; Borhani Haghighi A; Ghorbel IB; Houman H
J Neuroimmunol; 2011 Apr; 233(1-2):249-53. PubMed ID: 21367463
[TBL] [Abstract][Full Text] [Related]
4. Increased IL-22 in cerebrospinal fluid of neuro-behçet's disease patients.
Belghith M; Maghrebi O; Ben Laamari R; Hanachi M; Hrir S; Saied Z; Belal S; Driss A; Ben Sassi S; Boussoffara T; Barbouche MR
Cytokine; 2024 Jul; 179():156617. PubMed ID: 38631183
[TBL] [Abstract][Full Text] [Related]
5. Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's Disease.
Belghith M; Maghrebi O; Cherif A; Bahrini K; Saied Z; Belal S; Sassi SB; Barbouche MR; Kchaou M
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35956031
[TBL] [Abstract][Full Text] [Related]
6. Discriminative expression of CD39 and CD73 in Cerebrospinal fluid of patients with Multiple Sclerosis and Neuro-Behçet's disease.
Bahrini K; Belghith M; Maghrebi O; Bekir J; Kchaou M; Jeridi C; Amouri R; Hentati F; Belal S; Ben Sassi S; Barbouche MR
Cytokine; 2020 Mar; 130():155054. PubMed ID: 32151963
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: Correlation with NLRP3 inflammasome.
Hamzaoui K; Borhani-Haghighi A; Dhifallah IB; Hamzaoui A
J Neuroimmunol; 2022 Apr; 365():577820. PubMed ID: 35123164
[TBL] [Abstract][Full Text] [Related]
8. Significance of immunoglobulins synthesis with central nervous system involvement in Neuro-Behçet's disease.
Zhan H; Cheng L; Liu Y; Xu H; Feng X; Liu Y; Li H; Li Z; Wang S; Jin H; Zheng W; Hao H; Li Y
Clin Chim Acta; 2024 Jun; 559():119681. PubMed ID: 38643816
[TBL] [Abstract][Full Text] [Related]
9. Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Behçet's disease: BAFF is correlated with progressive dementia and psychosis.
Sumita Y; Murakawa Y; Sugiura T; Wada Y; Nagai A; Yamaguchi S
Scand J Immunol; 2012 Jun; 75(6):633-40. PubMed ID: 22340436
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of neuro-Behçet's disease.
Hamzaoui K; Maître B; Hamzaoui A
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S52-7. PubMed ID: 19796534
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behçet patients.
Taşçi B; Direskeneli H; Serdaroglu P; Akman-Demir G; Eraksoy M; Saruhan-Direskeneli G
Clin Exp Immunol; 1998 Jul; 113(1):100-4. PubMed ID: 9697991
[TBL] [Abstract][Full Text] [Related]
12. BAFF is up-regulated in central nervous system of neuro-Behçet's disease.
Hamzaoui K; Houman H; Hentati F; Hamzaoui A
J Neuroimmunol; 2008 Aug; 200(1-2):111-4. PubMed ID: 18625522
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
Kaabachi W; Bouali E; Berraïes A; Dhifallh IB; Hamdi B; Hamzaoui K; Hamzaoui A
Immunol Lett; 2017 Oct; 190():177-184. PubMed ID: 28811236
[TBL] [Abstract][Full Text] [Related]
14. The Cerebrospinal Fluid Presentations of Neuro-Bechet Disease, a Way to Know the Etiopathogenesis and Improve Armamentarium.
Banerjee S; Hamzoui K; Safari A; Borhani-Haghighi A
Iran J Immunol; 2021 Sep; 18(3):170-178. PubMed ID: 34596581
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis.
Hirohata S; Kikuchi H; Sawada T; Nagafuchi H; Kuwana M; Takeno M; Ishigatsubo Y
Mod Rheumatol; 2012 Jun; 22(3):405-13. PubMed ID: 21935641
[TBL] [Abstract][Full Text] [Related]
16. Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Behçet's disease.
Hirohata S; Kikuchi H
Intern Med; 2012; 51(24):3359-65. PubMed ID: 23257520
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome.
Hirohata S; Isshi K; Oguchi H; Ohse T; Haraoka H; Takeuchi A; Hashimoto T
Clin Immunol Immunopathol; 1997 Jan; 82(1):12-7. PubMed ID: 9000037
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid level of neurofilament light chain is associated with increased disease activity in neuro-Behçet's disease.
Karaaslan Z; Şanlı E; Timirci-Kahraman Ö; Yılmaz V; Akbayır E; Koral G; İçöz S; Gündüz T; Küçükali Cİ; Kürtünvü M; Tüzün E
Turk J Med Sci; 2022 Aug; 52(4):1266-1273. PubMed ID: 36326394
[TBL] [Abstract][Full Text] [Related]
19. Myelin basic protein and index for neuro-Behçet's disease.
Zhan H; Cheng L; Wang X; Jin H; Liu Y; Li H; Liu D; Zhang X; Zheng W; Hao H; Li Y
Clin Immunol; 2023 May; 250():109286. PubMed ID: 36907539
[TBL] [Abstract][Full Text] [Related]
20. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
